Baxter’s stock price fell to $36.42. Shareholders have lost 7.3% of their capital, which is disappointing considering the S&P ...

Artisan Partners, an investment management company, released its “Artisan Mid Cap Value Fund” fourth quarter 2024 investor ...

D EERFIELD, IL – Baxter International Inc. (NYSE:BAX), a global leader in medical products with a market capitalization of $16.65 billion and annual revenue of $15.06 billion, announced today ...

Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion ...

Baxter Healthcare Corp.’s injectable drug for treating severely low blood pressure doesn’t literally infringe five Nevakar ...

Baxter's Voalte platform is a unified digital care communications solution. The Linq device integrates with existing products in Baxter's connected care portfolio including Voalte mobile ...

MEC Aerial Work Platforms, a leading provider of innovative solutions for the aerial industry, announces three major ...

offset by select product/market exits. Guidance: Baxter expects 2025 adjusted EPS of $2.45-$2.55 versus consensus of $2.47, with sales growth of 5%-6% on a reported basis and 4%-5% on an organic ...

Feb 20 (Reuters) - Baxter International (BAX.N), opens new tab on Thursday forecast 2025 profit above Wall Street estimates banking on strong sales of its medical devices, sending the company's ...

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products and Therapies ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.